Agreed - I'm certainly waiting to see what deals are realised off the back of the US patent. More broadly, research into exosomes continues to grow at an accelerating pace - which is positive for the pick and shovel play in Exopharm. I'd also note that EX1 is presenting at the Biotech Showcase, which is taking place over 10-12 Jan. Immugene and Radiopharm are also presenting there - will be interesting to see any company release on what will be presented.
Where has the chatter gone?, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $12.95K | 681.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1577577 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 404900 | 2 |
View Market Depth
| Last trade - 13.12pm 05/07/2024 (20 minute delay) ? |
| TYP (ASX) Chart |